Nephrogenic Systemic Fibrosis With Gadollinum

• Status: Unknown status
• Trial end date: 2012-08-01
• Target enrollment: 0
• Participant gender: All

Summary

Recently there is increasing reports of NEPHROGENIIC SYSTEMIC FIBROSIS(NSF) in patients with severe renal failure mainly in patients under dialysis in whom gadollinum is being used.

The investigators will evaluate the prevalence and severity of NSF in patients with different degree of renal failure whom underwent imaging with Gadolinum.

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Imam Khomeini Hospital
• Collaborator: Tehran Heart Center

Criteria

Inclusion Criteria:

• Renal Failure

• Use of Gadollinum

Exclusion Criteria:

• No consent

• Age under 18